Position in XGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$465
-$2,026 QoQ
Shares Held
100
-72.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 57 holders
Holding Since
Mar 2022
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FMR LLC holds $20,923,751,494 across 34 Diagnostics & Research names. XGN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
14,084,488 | $7,061,398,899 | |
| 2 | DHR |
Danaher Corp /De/
|
29,540,895 | $5,626,949,677 | |
| 3 | NTRA |
Natera, Inc.
|
5,451,396 | $1,479,781,442 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
4,239,752 | $961,533,354 | |
| 5 | ICLR |
Icon PLC
|
5,271,321 | $915,681,168 | |
| 6 | GH |
Guardant Health, Inc.
|
5,488,272 | $823,405,446 | |
| 7 | ILMN |
Illumina, Inc.
|
4,523,417 | $795,352,409 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,076,167 | $674,267,260 |
All Filings in XGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465 | 100 | Shares | Defined | 2026-08-13 | |
| 2025-06-30 | $2,491 | 357 | Shares | Defined | 2025-08-14 | |
| 2022-06-30 | $947 | 165 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,011 | 126 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||